Current status of HIV therapy: I. Antiretroviral agents.
Zidovudine has proved to be an important palliative agent in all stages of HIV infection. It delays progression of disease in patients with asymptomatic or mildly symptomatic infection and decreases the frequency and severity of opportunistic disease in those with AIDS. The search for other, more effective antiretroviral agents goes on, with some promising possibilities.
National Institute of Allergy and Infectious Diseases, Bethesda.
D F
DF
Hoth
M W
MW
Myers
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D010166:Palliative Care; D014779:Virus Replication / Q000187:drug effects; D015215:Zidovudine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine